Sabra Health Care REIT, Inc. (NASDAQ:SBRA – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the ten analysts that are covering the stock, MarketBeat.com reports. Three analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $17.30.
A number of analysts recently issued reports on the company. Truist Financial increased their price objective on Sabra Health Care REIT from $16.00 to $18.00 and gave the stock a “buy” rating in a report on Wednesday, September 4th. Citigroup upgraded Sabra Health Care REIT from a “neutral” rating to a “buy” rating and increased their price objective for the company from $17.00 to $20.00 in a research report on Friday, September 13th. Finally, Scotiabank raised their price target on Sabra Health Care REIT from $15.00 to $17.00 and gave the stock a “sector perform” rating in a research report on Monday, August 26th.
View Our Latest Stock Analysis on SBRA
Institutional Investors Weigh In On Sabra Health Care REIT
Sabra Health Care REIT Stock Performance
NASDAQ:SBRA opened at $18.44 on Monday. The stock has a market cap of $4.32 billion, a P/E ratio of 92.20, a price-to-earnings-growth ratio of 2.72 and a beta of 1.26. The company has a current ratio of 4.27, a quick ratio of 4.27 and a debt-to-equity ratio of 0.89. The stock’s 50-day moving average is $17.14 and its 200-day moving average is $15.46. Sabra Health Care REIT has a 1-year low of $12.83 and a 1-year high of $19.32.
Sabra Health Care REIT (NASDAQ:SBRA – Get Free Report) last announced its quarterly earnings results on Wednesday, August 7th. The real estate investment trust reported $0.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.34 by ($0.24). Sabra Health Care REIT had a return on equity of 1.87% and a net margin of 7.83%. The company had revenue of $176.14 million for the quarter, compared to the consensus estimate of $166.54 million. During the same quarter last year, the company posted $0.34 EPS. The company’s quarterly revenue was up 9.3% compared to the same quarter last year. Equities research analysts anticipate that Sabra Health Care REIT will post 1.38 earnings per share for the current year.
Sabra Health Care REIT Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, August 30th. Shareholders of record on Monday, August 19th were given a dividend of $0.30 per share. The ex-dividend date was Monday, August 19th. This represents a $1.20 dividend on an annualized basis and a yield of 6.51%. Sabra Health Care REIT’s dividend payout ratio (DPR) is presently 600.00%.
Sabra Health Care REIT Company Profile
As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.
Read More
- Five stocks we like better than Sabra Health Care REIT
- Stock Sentiment Analysis: How it Works
- Simon Property REIT: A Safe Bet for Growth and Steady Dividends
- Roth IRA Calculator: Calculate Your Potential Returns
- CarMax’s Impressive Rally: What Investors Should Watch Next
- EV Stocks and How to Profit from Them
- MarketBeat Week in Review – 9/23 – 9/27
Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.